Further analysis of the transcytosis of free polypeptides and polypeptide-coated nanobeads in rabbit nasal mucosa. J Appl Physiol 91: [211][212][213][214][215][216][217] 2001.-In rabbit nasal mucosa, free polypeptides and polypeptide-coated nanospheres are actively absorbed by the M cells present in specialized areas of the epithelium. Because polypeptide-coated nanosphere transport was abolished in the presence of free polypeptides, free polypeptides and polypeptide-coated nanospheres are shown here to compete. Fluxes of polypeptide-coated nanospheres with 356, 490, and 548 nm diameters have been compared. BSA-coated beads were poorly transported, at the same rate, when bead diameters were 356 or 490 nm [net flux of ϳ2-2.5 ϫ 10 6 nanospheres (nan) ⅐ cm Ϫ2 ⅐ h Ϫ1 ]; however, their net transport largely increased toward a value of 25 ϫ 10 6 nan ⅐ cm
nanospheres (nan) ⅐ cm
Ϫ2 ⅐ h Ϫ1 ]; however, their net transport largely increased toward a value of 25 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h
Ϫ1
at a diameter of 548 nm. Insulin-coated beads displayed a net flux that was significantly higher than BSA-coated beads but equally were transported at the same rate (net flux of ϳ8.0 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h
) at diameters of 356 or 490 nm; once again, their net flux significantly increased toward a value of 25 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 , if the bead diameter was 548 nm. Insulin plus anti-insulin IgG-coated 490-nm-diameter beads displayed a very high net flux, although not yet saturating (ϳ60 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 ); however, a significantly lower saturated net flux (once again ϳ25 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 ) was shown with 548-nm-diameter beads. In conclusion, 1) in the range of 356-490 nm diameter, net transport was independent of bead diameter and, conversely, largely dependent on the coating polypeptides, and 2) at 548 nm diameter, nanospheres tended to be transferred at similar rates independently of coating kind and the maximal net transport capacity of the mucosa was reduced. The suspension viscosity largely increased with 548-nm polypeptide-coated nanospheres; this fact is hypothetically proposed to be the cause of these events.
polypeptide active transport; antigen sampling; M cells; insulin; antibodies SPECIFIC ACTIVE ABSORPTION of polypeptides, supported by a selective transcytosis, has been shown across the rabbit nasal mucosa (3, 4, (6) (7) (8) ; it occurs through the M cells of specialized epithelial areas and is correlated with organized subepithelial lymphoid tissue (5, 11) . Polypeptides can be transported either presented free in the bathing solution or adsorbed on latex nanospheres (3, 4, (6) (7) (8) . Observations with this latter system have shown that net transport is selective for the different polypeptides; antibodies are preferred, especially if they are oriented with F c outside and F ab bound specifically to their antigen adsorbed on the bead (6, 14) . The theoretical and actual maximal transport capacities of the epithelium have been assessed by kinetic analysis of the transport as a function of bead concentration and coating (14) .
The aim of this paper is to further characterize the transcytotic pathway by investigating 1) whether free polypeptides and polypeptide-coated nanospheres are transported via the same pathway, 2) how nanoparticle size affects fluxes, and 3) whether the transport rate of the polypeptide carried by nanospheres is less than, equal to, or larger than the transport rate of the free polypeptide. Thus the results of this paper, besides the physiological interest, may have an impact on whether the transport of polypeptides after nasal application could be increased and how this could be accomplished.
MATERIALS AND METHODS
Male New Zealand White rabbits (weight of ϳ3 kg) were killed by cervical dislocation, and the nasal mucosae from the roof of both nostrils were mechanically excised, washed with Krebs-Henseleit saline at room temperature, and mounted on frames between two Teflon chambers, with the area corresponding to the upper concha exposed in the window (area of 0.3 cm 2 ). The two chambers were filled with 1 ml of Krebs-Henseleit saline and bubbled with prehumidified 95% O 2 ϩ 5% CO2 to oxygenate the tissue, maintain the pH at 7.4, and stir the solution.
The experiments were carried out at a monitored temperature of 27 Ϯ 1°C. At this temperature, the ion and polypeptide transport is one-half of that measured at 37°C, but the isolated mucosa is stable and viable for hours (6, 9) ; on the other hand, the nostril temperature is lower than 37°C. The viability of the epithelium was checked at the beginning, during, and end of each experiment by measuring the trans-epithelial potential difference (Vms), as previously reported (8, 9) ; V ms was 4.6 Ϯ 0.1 and 6.6 Ϯ 0.2 mV (submucosa positive) at the beginning and end of the 2-h experiment, respectively, across the 260 mucosae used.
The unidirectional mucosa-submucosa (J ms) and submucosa-mucosa (J sm) fluxes of free insulin or polypeptide-coated nanospheres were determined for 2 h, one on the right and the other on the left mucosa from the same animal (with random combinations), using the previously described protocol (6, 8) . The fluxes of free insulin were expressed as picomoles per centimeter squared per hour (pmol ⅐ cm Ϫ2 ⅐ h Ϫ1 ); those of nanospheres were expressed as nanospheres (nan) per centimeter squared per hour (nan ⅐ cm Ϫ2 ⅐ h Ϫ1 ). Jms and Jsm were considered unidirectional because the maximal concentration of insulin or nanospheres reached in the flux chamber was 10 Ϫ4 to 10 Ϫ5 compared with that applied in the opposite donor chamber.
Insulin fluxes. After a 30-min preincubation with KrebsHenseleit saline, 1 ml of solution with insulin at the appropriate concentration was added to the donor chamber. One minute later, 20 l of saline were withdrawn to measure the initial insulin concentration; 2 h later, the final insulin concentration was measured in the total withdrawn saline. With nominal 6.5 ϫ 10 Ϫ6 M insulin, the initial and final concentrations were 6.2 Ϯ 0.1 and 5.3 Ϯ 0.1 ϫ 10 Ϫ6 M (n ϭ 14); with nominal 26 ϫ 10 Ϫ6 M insulin, the initial and final concentrations were 24.9 Ϯ 0.3 and 24.0 Ϯ 0.4 ϫ 10 Ϫ6 M (n ϭ 14); with nominal 52 ϫ 10 Ϫ6 M insulin, the initial and final concentrations were 49.2 Ϯ 0.7 and 51.8 Ϯ 0.9 ϫ 10 Ϫ6 M (n ϭ 14). The 2-h transport was referred to the mean insulin concentration in the donor saline and corrected by referring to the corresponding nominal concentration (measured flux ϫ nominal concentration/mean concentration). The total fluid in the flux chamber at the end of the experiment was diluted (1:2) with Krebs-Henseleit saline plus 14% BSA and centrifuged for 30 min at 4°C and 14,700 g in a Z360K Hermle centrifuge (Maschinenfabrik Berthold Hermle, Gosheim, Germany). Insulin measurements were performed with the "Enzimun-test Insulin" kit supplied by Boehringer Mannheim (Milan, Italy). The kit was designed to measure insulin in serum; thus the insulin in the Krebs-Henseleit solution was not determined. Insulin was again well determined if BSA was added to the sample of Krebs-Henseleit saline (final concentration of 7%). Insulin in Krebs-Henseleit saline tends to form aggregates, especially if salines are vigorously mixed; aggregates can be avoided by gently bubbling the gas mixture during the experimental incubation or gently stirring with a Teflon stick; after BSA addition, aggregates do not form. Finally, because the kit was prepared with anti-human insulin IgG and these antibodies only recognize 35% of bovine insulin (which we have generally used), human insulin was employed for these experiments.
Nanosphere fluxes. After a 30-min preincubation with Krebs-Henseleit saline, 1 ml of solution with polypeptidecoated nanospheres at the appropriate concentration was added to the donor chamber. One minute later, 10 l saline were withdrawn to measure the initial nanosphere concentration; 2 h later, the final nanosphere concentration was measured in the total withdrawn saline. Independently of nanosphere diameter, the nominal concentration was generally 3.3 ϫ 10 11 nan/ml. The measured initial and final concentrations were 3.30 Ϯ 0.01 and 3.15 Ϯ 0.02 ϫ 10 11 nan/ml (n ϭ 232).
The latex nanoparticles were "polybead polystyrene microspheres" with 490 nm mean diameter, as previously used; nanoparticles with 356 or 548 nm mean diameters were also used. All were supplied by Polysciences (Warrington, PA).
The bead concentration in the donor saline was measured with a Lambda 5 spectrophotometer (Perkin-Elmer, Norwalk, CT) at a wavelength of 600 nm. To prepare the calibration straight line, the reference bead concentrations were calculated on the basis of the solid latex contained in the vial supplied, the nanosphere diameter, and the polystyrene density (nominal concentrations). These concentrations were also directly measured in a Burker chamber after suitable dilution. Because of their very low concentration, the nanospheres transported by the mucosa were measured solely with the use of a Burker chamber. An Eclipse E600 dark-field microscope (ϫ600 magnification, Nikon Europe, Badhoevedorp, The Netherlands) was used for the Burker chamber determinations, taking advantage of the Tyndall effect. The ratio between the measured and nominal value of the nanosphere number was 1 if a Burker chamber contained in a 1.5-mm-thick glass slide was used.
The polypeptides were adsorbed on nanoparticles by using a previously described method (3, 14) . The polypeptide concentration in the medium used for the adsorption process was generally 6.5 ϫ 10 Ϫ6 M. Still unbound surface sites were completely blocked with BSA. When a double coating of the nanospheres with antibodies was necessary, a first coating by adsorption with 6.5 ϫ 10 Ϫ6 M bovine insulin was performed, after which the still unbound sites were blocked with BSA (as above); the nanospheres were then resuspended in KrebsHenseleit saline containing anti-insulin IgG at a concentration of 6.5 ϫ 10 Ϫ8 M (1:100 compared with that of insulin). The suspension was incubated at 4°C for 16 h on an orbital shaker and spun down at 11,000 rpm (7,260 g) for 10 min; the precipitate was then resuspended in Krebs-Henseleit saline. In both cases (monocoating or double coating), the final nanosphere concentration was generally adjusted to 3.3 ϫ 10 11 nan/ml. Variations in insulin and nanosphere concentrations are reported in RESULTS.
Viscosity measurements. A 100-l SGE Perfection syringe (SGE International) was used to measure the viscosity of the different nanosphere suspensions relative to water. The length and diameter of the capillary were 51 and 1.58 mm, respectively; together, the piston and related load weighed 32.2 g. The temperature was fixed at 27 Ϯ 1°C. The nanoparticles (356, 490, and 548 nm diameters) were coated with 6.5 ϫ 10 Ϫ6 M insulin (ϩBSA) and were at a concentration of 3.3 ϫ 10 11 nan/ml; for the 548-nm beads only, the concentration was also diluted to 2.3 ϫ 10 11 nan/ml. Water or bead suspension (100 l) was sucked into the vertically fixed syringe, and the piston (with load) was allowed to run down and drain the fluid gravimetrically for the entire capillary length. The draining time was measured with a chronometer able to determine thousandths of a second. The syringe was washed with ethanol after every fluid change. The viscosity relative to water (r) was measured as the ratio between the draining times of the bead suspensions and water (1) .
Materials and salines. BSA, murine monoclonal anti-human insulin immunoglobulin G1 (anti-insulin IgG or IgGins), and human sodium insulin (sodium salt) were supplied by Sigma-Aldrich Chemie (Steinheim, Germany); bovine sodium insulin (sodium salt) was supplied by Calbiochem (Lucerne, Switzerland).
The Krebs-Henseleit solution had the following composition (in mM): 142.9 Na ϩ , 5. Statistics. The results are expressed as means Ϯ SE. Student's t-test for unpaired or, when possible, paired data was used for the statistical analysis. Interpolating straight lines and curves were calculated by linear and nonlinear regressions. Figure 1 shows that the two unidirectional fluxes (J ms and J sm ) were not statistically different when donor chambers contained up to 6.5 ϫ 10 Ϫ6 M human insulin. With increasing insulin concentrations, J sm increased linearly and J ms was statistically larger than J sm , so that a net absorptive flux (J net ) was measured, with saturation kinetics. J net data points could be well interpolated by either a sigmoidal curve or a rectangular hyperbola intercepting the x-axis at 6.4 M (r 2 ϭ 1 in both cases). Halfmaximal concentrations (S 0.5 , K m ) were 18.0 Ϯ 0.0 M in the former case and 17.0 Ϯ 1.4 M in the latter case. The maximal J net (J max ) was 6.6 Ϯ 0.0 and 7.9 Ϯ 0.3 pmol ⅐ cm Ϫ2 ⅐ h Ϫ1 , respectively. The Hill number for the sigmoid was 3.4 Ϯ 0.0. The kinetics of the passive flux (J sm ) followed a straight line up to at least 52 ϫ 10 Ϫ6 M insulin (r 2 ϭ 0.9865): y ϭ (0.12 Ϯ 0.02)x. On this basis, it is possible to calculate a permeability coefficient of 0.33 nm/s.
RESULTS

Free insulin fluxes.
Competition between free insulin and insulin-coated nanospheres for transcytosis. To obtain J max of insulincoated nanospheres, beads (490 nm diameter, as previously used) were coated in the presence of 9.9 ϫ 10 Ϫ6 M bovine insulin. Figure 2 shows that J ms was equal to 13.3 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 and statistically larger than J sm (P Ͻ 0.01); J net was 10.2 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h
Ϫ1
. This value was not statistically different from that previously observed for J max (6) . If the experiment was repeated with donor salines containing both nanospheres (coated in the same way) and free bovine insulin (20 ϫ 10 Ϫ6 M), the passive bead J sm was statistically unmodified, whereas J ms decreased to a value not statistically different from J sm so that J net was abolished.
Effect of bead diameter on nanosphere fluxes and donor saline viscosity. Nanospheres with smaller (356 nm) or larger (548 nm) diameters than the diameter we generally adopted (490 nm) and the 490-nm nanospheres were coated with 6.5 ϫ 10 Ϫ6 M BSA or bovine insulin at the usual fixed concentration of 3.3 ϫ 10 11 nan/ml. Because bead concentration was equal, the total solid latex in the saline increased with nanoparticle diameter. This fact can cause changes in viscosity of the donor saline. Thus r was measured by comparing the draining times of water and bead suspensions forced to move along a capillary by equal pressures. Figure 3 shows the results obtained. The r of bead suspensions was significantly larger than that of water in any case (P Ͻ 0.01). However, the viscosity of suspensions of 356-or 490-nm beads was larger than that of water by only 1.50 and 1.59 times, respectively, and these two values were not significantly different from each other. Conversely, r of the suspension of 548-nm beads was 3.45 and approximated that of the cytosol. An equal result was obtained with 548-nm beads at a little lower concentration (2.3 ϫ 10 11 nan/ml). Ϫ6 M insulin in the donor saline. Insulin concentration for bead coating was 9.9 ϫ 10 Ϫ6 M; bead concentration was 3.3 ϫ 10 11 nan/ml. Histograms represent means Ϯ SE. Open bars and solid bars, without (n ϭ 8) and with free insulin (FI; n ϭ 5) in the donor saline, respectively.
• • P Ͻ 0.01 compared with the corresponding Jsm; **P Ͻ 0.01 compared with zero.
The unidirectional fluxes of BSA-or bovine insulincoated nanospheres with diameters equal to 356, 490, and 548 nm are reported in Table 1 ; the corresponding J net values are shown in Fig. 4 .
With nanospheres of 356 or 490 nm diameter, J ms , J sm , and J net displayed values independent of diameter; conversely, J ms and J net were dependent on coating, being significantly larger when coated with insulin compared with when coated with BSA, as already previously observed with 490-nm nanospheres (6) . In two experiments with 356-nm beads coated with bovine insulin, the presence of free bovine insulin in the bath (20 ϫ 10 Ϫ6 M) abolished the J net (not shown), as shown above for the 490-nm beads.
Conversely, nanospheres with 548 nm diameter, compared with the nanospheres with a lower diameter, displayed 1) a significant decrease in J sm by ϳ10 times and 2) a significantly large increase in J ms and J net . J net of BSA-coated nanospheres increased from ϳ2 to 14.5 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 , that is, by about seven times; J net of insulin-coated nanospheres increased from ϳ8 to 26.5 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 , that is, by more than three times. Thus the relative increase was larger Fig. 3 . Viscosity of suspensions of 356-, 490-, and 548-nm beads relative to water. Relative viscosity (r) is shown on the right ordinate; nanosphere diameter is shown on the abscissa. The r was measured as the ratio between draining times of bead suspensions and water forced to move along a capillary by equal pressures. Draining time is shown on the left ordinate. Beads (3.3 ϫ 10 11 nan/ml) were coated with 6.5 ϫ 10 Ϫ6 M insulin (ϩBSA) following the usual procedure (see MATERIALS AND METHODS); 548-nm-diameter beads were also diluted to 2.3 ϫ 10 11 nan/ml. Data points are means Ϯ SE (n ϭ 6 in each case). Data point concerning 2.3 ϫ 10 11 nan/ml concentration (beads with 548-nm diameter) overlaps with that for 3.3 ϫ 10 11 nan/ml concentration. A second batch of coated beads gave the same results (n ϭ 12 in each case; not shown in the figure). *P Ͻ 0.01 compared with water viscosity;
• P Ͻ 0.01 compared with 360-and 490-nm bead viscosity. Values are means Ϯ SE; n ϭ no. of experiments. After a 30-min preincubation, 3.3 ϫ 10 11 /ml polypeptide-coated nanospheres (polystyrene) were added to the mucosal or submucosal compartment, and the overall corresponding unidirectional transports [mucosa-submucosa ( Jms) and submucosa-mucosa ( Jsm)] during a 2-h period were determined with the use of a Burker chamber and expressed as equivalent fluxes. Bead coating was carried out by incubating the nanospheres with the 6.5 ϫ 10 Ϫ6 M polypeptide at 37°C for 90 min. Final nanosphere concentration was 3.3 ϫ 10 11 nanospheres (nan)/ml. * P Ͻ 0.05, † P Ͻ 0.01, both compared with the corresponding Jsm.
with BSA coating, but the J net value reached was significantly larger with insulin coating (P Ͻ 0.05). To check whether the measured J net was active, the tissue was treated with monoiodoacetate (3 ϫ 10 Ϫ3 M) and dinitrophenol (10 Ϫ4 M) for the entire 2-h experimental period, to prevent ATP formation by metabolism. The V ms dropped from 4.5 Ϯ 0.3 to 0.0 Ϯ 0.0 mV (n ϭ 12), and the bead J net dropped to close to zero without significant changes in the passive flux J sm (results reported in Table 1 and Fig. 4) .
Using the reference nanospheres with 490 nm diameter, we previously observed that a very high J net , 8 and 30 times larger than that obtained with insulin and BSA coatings, respectively, was obtained with a double coating of insulin (adsorbed on the nanosphere) and anti-insulin IgG bound to insulin with the F c oriented outward (14) . This is confirmed in Table 2 (which reports J ms and J sm ) and Fig. 5 (which reports J net ). On the basis of kinetics measurements, this J net was about one-half of the maximal theoretical J net achievable, when the concentration of beads with the same coating was increased (14) . With the same double coating but with 548-nm nanoparticles, not only is no stimulation observed (unlike what happens for BSA or insulin coating), but a drastic J net decrease actually occurs: J net drops significantly (P Ͻ 0.01) from ϳ59 to 22 ϫ 10 6 nan ⅐ cm
, a value not significantly different from that obtained with insulin coating on these nanospheres. Moreover, this J net is at saturation rate: a decrease in nanoparticle concentration from 3.3 to 2.3 ϫ 10 11 nan/ml does not significantly change J net , which remains at ϳ25 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 (Table 2 , Fig. 5) , Conversely, the same reduction in concentration with 490-nm nanoparticles produces a significant J net decrease from ϳ59 to 43 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 (Table 2 , Fig. 5 ), as would be expected (14) . In conclusion, a J net approximately equal to 25 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 , namely, that already obtained with insulin coating, seems to be the J max achievable with 548-nm beads.
DISCUSSION
Free insulin passive flux. We have previously analyzed the passive fluxes of many organic molecular markers, with different molecular weights, across the mucosa of the upper concha of the rabbit, including two polypeptides, namely elcatonin [molecular weight (M r ) ϭ 3,362] and adrenocorticotropic hormone (M r ϭ 4,500) (8) . We have shown that, in this mucosa, two populations of inter(para)cellular pores exist, the first comprising numerous pores, which allow free diffusion of molecules with M r up to 1,000, and the second comprising a few large pores (up to 4-nm radius) allowing free diffusion (with low permeability) of molecules with M r up to 4,000, whose J sm kinetics were linear at least up to 25 mM (8) . Elcatonin, which is dimeric in solution and thus has an actual M r of 6,724, displayed lower permeability than these latter markers; kinetics of the passive flux J sm saturated over a concentration of only 2.4 M, indicating movements by drastically restricted diffusion (4, 8) .
The human sodium insulin we have now tested has intermediate diffusional properties. With a M r ϭ 5,749.5, i.e., only slightly smaller than that of dimeric elcatonin, and permeability of the same order as elcatonin, it displays linear J sm kinetics at least up to 52 M. These observations suggest that insulin can move either at the borderline of free diffusion or, more prob- Values are means Ϯ SE; n ϭ no. of experiments. Bead coating was carried out by incubating the nanospheres with 6.5 ϫ 10 Ϫ6 M insulin at 37°C for 90 min. After the washings with BSA, so as to completely block still unbound surface sites, the nanospheres were incubated with 6.5 ϫ 10 Ϫ8 M anti-insulin IgG at 4°C for 16 h on an orbital shaker (double coating). Final nanosphere concentration was 3.3 or 2.3 ϫ 10 11 nan/ml. * P Ͻ 0.05 compared with Jms obtained with a bead concentration of 3.3 ϫ 10 11 nan/ml; † P Ͻ 0.01 compared with the corresponding Jsm.
ably, with only a less restricted diffusion than elcatonin dimer.
In any event, the small population of large pores begins to hamper free diffusion of molecules with M r ϭ 5,000-7,000 and a few nanometer diameter. Thus it is surprising to observe passive fluxes of nanospheres with up to ϳ500 nm diameter, even if their diffusion is restricted (6, 14) . Clearly, they must move through a third smallest population of pores with 100-nm diameter but negligible total area, even compared with the sole second pore population. In agreement, the permeability coefficient of the 490-nm beads, which can be calculated from Table 1 , is 0.03 nm/s, i.e., 11 times lower than that of free insulin. Thus the majority of free polypeptide molecules moves through the larger area of the first two populations of pores and a negligible minority moves through the third population. The third class of pores probably is not located in intercellular junctions but in a very few nanolesions of the epithelium, such as damaged cells (3, 6) .
Free insulin J net . A net absorption of human insulin occurs above a concentration of 6.5 M. It follows either sigmoidal kinetics, with three cooperating binding sites, or hyperbolic kinetics, with a threshold at ϳ6.5 M insulin. In any event, J max is ϳ7 pmol ⅐ cm Ϫ2 ⅐ h Ϫ1 , about twice that of elcatonin, and the half-maximal concentration (S 0.5 , K m ) is ϳ18 M, more than five times that of elcatonin (4) . This means that the transcytotic system displays less affinity but a higher transport capacity for human insulin than for elcatonin. The difference in net transport capacity (if it is not due to the different assays used or the different time periods of the measurements) may suggest that different pathways (receptors?) are involved in the transcytosis of the two polypeptides. Conversely, insulin and elcatonin adsorbed on nanospheres display approximately the same J max and the same half-maximal concentration (6) . The different behavior for insulin might also be explained by the fact that bovine insulin, instead of human insulin, was adsorbed on the nanospheres; however, a certainly important fact is that the molecules adsorbed can be forced into positions that can favor or hamper the binding, so as to change the affinity. Otherwise, it can be that different pathways are involved in the transport of free polypeptides and polypeptide-coated nanospheres.
On this basis, to clarify whether free insulin and insulin-coated nanospheres use the same pathway, competition between bovine insulin-coated nanospheres and free bovine insulin, at a concentration certainly larger than K m (S 0.5 ), was investigated. The result, complete abolition of bead J net , shows that pathways for either transport are identical.
Effect of nanosphere diameter on fluxes. The results reported show that BSA-or insulin-coated nanospheres are transported at a rate independent of nanosphere diameter ranging from 356 to 490 nm. Equally, passive permeability is not significantly affected. However, the change in diameter from 490 to 548 nm is critical, as the passive flux J sm decreases by ϳ10 times and J net increases by 7 times (BSA coating) or 3 times (insulin coating) and, in absolute values, to a maximum of ϳ25 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 (insulin coating). The decrease in J sm could be predicted because nanospheres with a diameter of 490 nm already cross the mucosa by restricted diffusion, probably single-file diffusion (6, 14) . Thus a further increase in diameter can only reduce permeability.
The increase in J net could not be so easily predicted, since the increase in diameter should reduce the possibility of bead accommodation in the endocytotic pits and should reduce transport. Moreover, J net increase cannot be due to an increase in polypeptide loading on larger nanoparticles because 1) BSA coating corresponds in all kinds of nanospheres to 100% of bead surface (as sites still unbound after coating incubation are blocked with BSA), 2) by increasing insulin loading, 490-nm nanospheres display a maximal transport of only 10 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 , very far from the required 25 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 obtained with 548-nm nanospheres, and this occurs with coating concentrations very far from those saturating the bead surface (this paper and Ref. 6 ).
Bead concentration being constant, the change in bead diameter introduces a change in solution viscosity as the only dependent variable. Whereas viscosity and net transport are not significantly different for 356-and 490-nm beads, viscosity and net transport abruptly increase in parallel for 548-nm nanoparticles. Cytosol viscosity is 5-20 times that of water and, avoiding cells with ectoplasm, nearer to 5 (2, 12, 13) . Thus the viscosity of the suspension of 548-nm beads approaches that of cytosols. It has been predicted theoretically and shown by experiments on transferrinmediated endocytosis in two different cell lines that, with extracellular viscosity close to cytosolic viscosity, the cell plasma membrane tends to invaginate more rapidly so that endocytic pits and vesicles accelerate their formation rate; this accelerates endocytosis (10) . At present, we have no direct evidence in favor of a stimulation of the apical endocytosis in the nasal epithelium under the conditions described, which may be caused by the observed increase in viscosity of the bathing saline. Hypothetically, we can suppose that such a relationship exists so that all apical processes of the transcytosis and as a consequence the whole pathway are altered. In this case, the rearrangement must involve a stimulation of J net of BSA-or insulin-coated nanospheres, which are low with 356-to 490-nm beads; conversely, it must cause a decrease of the J net of insulin ϩ anti-insulin IgG-coated nanoparticles, which is highest with the smaller beads.
In conclusion, the maximal net transport capacity of the mucosa is largely reduced to ϳ25 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 with the 548-nm beads. Conclusions. Because nasal application of polypeptide hormones and related active compounds is a therapeutic strategy, on the basis of the present results, it must be concluded that the use of 548-nm beads produces improvements in the low transports but a drastic decrease in the maximal transport capacity of the mucosa. With 490-nm beads, which seem to support the best maximal net transport capacity, the J max of insulin adsorbed on nanospheres can be compared with free insulin J max . At the maximal concentration of soluble bovine insulin (ϳ470 M), 2.20 ϫ 10 Ϫ7 pmol can be loaded on one 490-nm bead; this corresponds to 83% of the maximal loading (6) . The maximal loading can be reached with the more soluble human insulin (2.65 ϫ 10 Ϫ7 pmol/nan). J max of insulin-coated nanospheres is ϳ10 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 and can be already reached with low loadings; if net transport is stimulated by a double coating with insulin ϩ IgG ins , J max can reach ϳ90 ϫ 10 6 nan ⅐ cm Ϫ2 ⅐ h Ϫ1 (14) . Thus the J max of insulin adsorbed on nanospheres can be 2.6 pmol ⅐ cm Ϫ2 ⅐ h Ϫ1 in the first case (monocoating with only insulin) and 23.9 pmol ⅐ cm Ϫ2 ⅐ h Ϫ1 in the second case (double coating with insulin ϩ IgG ins ), the former being much less (37%) and the latter much more (3.4 times) than free insulin J max (ϳ7 pmol⅐ cm Ϫ2 ⅐ h
Ϫ1
).
